Copyright Reports & Markets. All rights reserved.

Global Veterinary Therapeutics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Veterinary Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Anti-inflammatory
    • 1.4.3 Parasiticides
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Veterinary Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Veterinary Clinics
    • 1.5.4 Drug Stores
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Veterinary Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Veterinary Therapeutics Growth Trends by Regions
    • 2.2.1 Veterinary Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Veterinary Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Veterinary Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Veterinary Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Veterinary Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Veterinary Therapeutics Players by Market Size
    • 3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Veterinary Therapeutics Market Concentration Ratio
    • 3.2.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2019
  • 3.3 Veterinary Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Veterinary Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Veterinary Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Veterinary Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Veterinary Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Veterinary Therapeutics Market Size (2015-2020)
  • 6.2 Veterinary Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Veterinary Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Veterinary Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Veterinary Therapeutics Market Size (2015-2020)
  • 7.2 Veterinary Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Veterinary Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Veterinary Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Veterinary Therapeutics Market Size (2015-2020)
  • 8.2 Veterinary Therapeutics Key Players in China (2019-2020)
  • 8.3 China Veterinary Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Veterinary Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Veterinary Therapeutics Market Size (2015-2020)
  • 9.2 Veterinary Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Veterinary Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Veterinary Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Veterinary Therapeutics Market Size (2015-2020)
  • 10.2 Veterinary Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Veterinary Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Veterinary Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Veterinary Therapeutics Market Size (2015-2020)
  • 11.2 Veterinary Therapeutics Key Players in India (2019-2020)
  • 11.3 India Veterinary Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Veterinary Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Veterinary Therapeutics Market Size (2015-2020)
  • 12.2 Veterinary Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Veterinary Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Veterinary Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Bayer AG
    • 13.1.1 Bayer AG Company Details
    • 13.1.2 Bayer AG Business Overview
    • 13.1.3 Bayer AG Veterinary Therapeutics Introduction
    • 13.1.4 Bayer AG Revenue in Veterinary Therapeutics Business (2015-2020))
    • 13.1.5 Bayer AG Recent Development
  • 13.2 Boehringer Ingelheim GmbH
    • 13.2.1 Boehringer Ingelheim GmbH Company Details
    • 13.2.2 Boehringer Ingelheim GmbH Business Overview
    • 13.2.3 Boehringer Ingelheim GmbH Veterinary Therapeutics Introduction
    • 13.2.4 Boehringer Ingelheim GmbH Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.2.5 Boehringer Ingelheim GmbH Recent Development
  • 13.3 Ceva Sante Animale
    • 13.3.1 Ceva Sante Animale Company Details
    • 13.3.2 Ceva Sante Animale Business Overview
    • 13.3.3 Ceva Sante Animale Veterinary Therapeutics Introduction
    • 13.3.4 Ceva Sante Animale Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.3.5 Ceva Sante Animale Recent Development
  • 13.4 Dechra Pharmaceuticals PLC
    • 13.4.1 Dechra Pharmaceuticals PLC Company Details
    • 13.4.2 Dechra Pharmaceuticals PLC Business Overview
    • 13.4.3 Dechra Pharmaceuticals PLC Veterinary Therapeutics Introduction
    • 13.4.4 Dechra Pharmaceuticals PLC Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.4.5 Dechra Pharmaceuticals PLC Recent Development
  • 13.5 Eli Lilly and Company (Elanco Animal Health)
    • 13.5.1 Eli Lilly and Company (Elanco Animal Health) Company Details
    • 13.5.2 Eli Lilly and Company (Elanco Animal Health) Business Overview
    • 13.5.3 Eli Lilly and Company (Elanco Animal Health) Veterinary Therapeutics Introduction
    • 13.5.4 Eli Lilly and Company (Elanco Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.5.5 Eli Lilly and Company (Elanco Animal Health) Recent Development
  • 13.6 Merck Animal Health
    • 13.6.1 Merck Animal Health Company Details
    • 13.6.2 Merck Animal Health Business Overview
    • 13.6.3 Merck Animal Health Veterinary Therapeutics Introduction
    • 13.6.4 Merck Animal Health Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.6.5 Merck Animal Health Recent Development
  • 13.7 Sanofi (Merial Animal Health)
    • 13.7.1 Sanofi (Merial Animal Health) Company Details
    • 13.7.2 Sanofi (Merial Animal Health) Business Overview
    • 13.7.3 Sanofi (Merial Animal Health) Veterinary Therapeutics Introduction
    • 13.7.4 Sanofi (Merial Animal Health) Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.7.5 Sanofi (Merial Animal Health) Recent Development
  • 13.8 Virbac
    • 13.8.1 Virbac Company Details
    • 13.8.2 Virbac Business Overview
    • 13.8.3 Virbac Veterinary Therapeutics Introduction
    • 13.8.4 Virbac Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.8.5 Virbac Recent Development
  • 13.9 Vetoquinol S.A.
    • 13.9.1 Vetoquinol S.A. Company Details
    • 13.9.2 Vetoquinol S.A. Business Overview
    • 13.9.3 Vetoquinol S.A. Veterinary Therapeutics Introduction
    • 13.9.4 Vetoquinol S.A. Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.9.5 Vetoquinol S.A. Recent Development
  • 13.10 Zoetis, Inc.
    • 13.10.1 Zoetis, Inc. Company Details
    • 13.10.2 Zoetis, Inc. Business Overview
    • 13.10.3 Zoetis, Inc. Veterinary Therapeutics Introduction
    • 13.10.4 Zoetis, Inc. Revenue in Veterinary Therapeutics Business (2015-2020)
    • 13.10.5 Zoetis, Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Veterinary Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Bayer AG
    Boehringer Ingelheim GmbH
    Ceva Sante Animale
    Dechra Pharmaceuticals PLC
    Eli Lilly and Company (Elanco Animal Health)
    Merck Animal Health
    Sanofi (Merial Animal Health)
    Virbac
    Vetoquinol S.A.
    Zoetis, Inc.

    Market segment by Type, the product can be split into
    Anti-inflammatory
    Parasiticides
    Other
    Market segment by Application, split into
    Hospitals
    Veterinary Clinics
    Drug Stores

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now